4//SEC Filing
Hayes Christopher G. 4
Accession 0001209191-23-055527
CIK 0001660334other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:32 PM ET
Size
7.2 KB
Accession
0001209191-23-055527
Insider Transaction Report
Form 4
Hayes Christopher G.
CHIEF LEGAL OFFICER
Transactions
- Sale
Common Stock
2023-11-14$2.93/sh−22,141$64,873→ 134,784 total - Sale
Common Stock
2023-11-15$2.97/sh−11,558$34,327→ 123,226 total
Footnotes (3)
- [F1]Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on August 24, 2023.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $3.07 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3).
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.95 to $3.00 inclusive.
Documents
Issuer
Verrica Pharmaceuticals Inc.
CIK 0001660334
Entity typeother
Related Parties
1- filerCIK 0001805359
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 4:32 PM ET
- Size
- 7.2 KB